KEDI U.S. Dividend100 90% Participation + Daily Options Premium Index

Q4 and full fiscal year 2026 earnings release scheduled. Analysts forecast EPS of $1.33 and revenue of $2.88 billion for the quarter. A 5% price impact based on historical volatility is estimated and scheduled.

The 2026 Annual Meeting of Shareholders on 2026-05-21 to be held virtually, scheduled.

Q1 2026 earnings release on 2026-05-19. Medium importance is estimated as earnings reports for a company of this size typically cause moderate price movement, scheduled.

MetLife announced it will release its first quarter 2026 financial results after the market closes on May 6, 2026, with a conference call on May 7, 2026, scheduled

Q1 2026 earnings results release after market close scheduled.

Williams plans to announce its first-quarter 2026 financial results after the market closes on Monday, May 4, 2026.. Medium importance justified by typical earnings-related price volatility of 5% or more, scheduled.

Chevron's Q1 2026 earnings release and conference call are scheduled for May 1, 2026. A preliminary update on April 9 forecasted significant negative timing effects and working capital outflows, which could impact the stock. scheduled

First quarter 2026 financial results are scheduled to be released on May 1, 2026. Medium importance is estimated as quarterly earnings often result in price volatility exceeding 5%, scheduled.

Bristol-Myers Squibb is scheduled to report its Q1 2026 financial results on April 30, 2026, with analysts forecasting EPS of $1.45. High impact is estimated as quarterly earnings are major market catalysts scheduled.

Merck & Co. is scheduled to release its Q1 2026 earnings on April 30, 2026; impact is estimated as neutral pending the actual report, scheduled.

T. Rowe Price is scheduled to release its Q1 2026 financial results on April 30, 2026. High importance is estimated as earnings reports typically result in significant price volatility, scheduled.

First quarter 2026 financial results and conference call scheduled for April 30, 2026. This is a recurring event, but earnings releases can have a significant price impact, so importance is estimated as Medium, scheduled.

ConocoPhillips is scheduled to release its Q1 2026 financial and operating results on 2026-04-30 before the market opens. Analysts forecast EPS of approximately $1.63. This event is scheduled.

First quarter 2026 financial results are scheduled to be released on April 30, 2026. A webcast for investors is scheduled for the same day. Earnings releases typically cause significant price volatility, estimated at 5% impact, and the release is scheduled.

Amgen is expected to report its Q1 2026 financial results after the market closes on April 30, 2026, scheduled. Analysts estimate a Low impact (~1-2%) as a standard scheduled reporting event, scheduled.

Qualcomm is scheduled to release its second quarter fiscal 2026 financial results after the market close on April 29, 2026. High importance is estimated due to the potential for significant price volatility following the announcement, scheduled.

Q3 fiscal 2026 earnings release scheduled for 2026-04-29. Analysts forecast EPS of $3.30. Importance is Medium as earnings surprises typically drive 5-10% price volatility forecasted.

First quarter 2026 financial results and quarterly dividend information to be released on April 28, 2026; estimated Medium importance as earnings releases typically result in price volatility ≥5%, scheduled.

The Coca-Cola Company is scheduled to release its first-quarter 2026 financial results on April 28, 2026, with analysts forecasting EPS of approximately $0.81; a 5% price impact is estimated based on historical earnings volatility, and the release is scheduled.

Mondelez International is scheduled to release its Q1 2026 financial results on 2026-04-28 after the market closes. Analysts forecast a potential drop in profit due to rising input costs, with an estimated market impact of ~5%, estimated.

United Parcel Service (UPS) is scheduled to release its first-quarter 2026 financial results before the market opens on April 28, 2026, with a conference call to follow, an event that is scheduled. A price impact of ≥5% is estimated based on historical earnings volatility.

Sysco is scheduled to announce its third quarter fiscal year 2026 financial results on April 28, 2026, with low impact expected.

Procter & Gamble is scheduled to announce its Q3 2026 earnings results and host a conference call on April 24, 2026, before the market opens. This is a future event, and its importance is estimated as High due to the potential for significant price impact upon release of the results scheduled.

High impact expected as earnings reports typically drive significant volatility; Q1 2026 earnings release is scheduled.

CME Group is scheduled to announce its earnings for the first quarter of 2026 before the market opens on April 22, 2026; earnings releases typically cause moderate volatility scheduled

Texas Instruments is scheduled to release its Q1 2026 earnings after the market closes on April 22, 2026, scheduled. Importance is Medium as earnings typically cause 5-10% price movement.

UnitedHealth Group is scheduled to release its first quarter 2026 financial results. Analysts forecast an adjusted EPS of approximately $6.69. This release is highly anticipated for signs of recovery amid rising medical costs. A High importance is assigned as quarterly earnings for a major Dow component can lead to price swings exceeding 10% depending on the results scheduled.

Bank OZK is set to report first-quarter 2026 earnings after market close on 2026-04-21; routine quarterly results typically move regional bank shares modestly, scheduled.

High importance estimated due to potential for significant volatility; Regions Financial Corp. to announce Q1 2026 financial results before market open on April 17, 2026, with an executive webcast scheduled.

State Street is scheduled to announce its first-quarter 2026 financial results on 2026-04-17 before the market opens, with a conference call to follow. Analysts forecast year-over-year growth in revenue and earnings, and high importance is estimated due to potential for significant price volatility, scheduled.

Abbott announced Q1 2026 results, beating revenue estimates but lowering its full-year 2026 adjusted EPS forecast to $5.38-$5.58, citing $0.20 of dilution from the Exact Sciences acquisition.

PepsiCo reported Q1 2026 earnings per share (EPS) of $1.61, beating analyst estimates of approximately $1.57. Revenue for the quarter was $19.44 billion, also surpassing expectations. The company affirmed its financial guidance for fiscal year 2026.

J.P. Morgan analysts downgraded Qualcomm stock to 'Neutral' and lowered the price target to $140 from $185, citing increased competition. Medium importance is estimated as such downgrades often lead to a 5-10% price impact, estimated.

Booz Allen's venture capital arm, Booz Allen Ventures, announced an investment in Ulysses, a developer of autonomous maritime vehicles, as part of its Series A funding round.

Comcast Business launched an Innovation Lab with partners including Dell and Digital Realty to co-develop and test enterprise solutions.

Scheduled for April 16, 2026, BTIG initiated coverage with a 'Buy' rating and a $300 price target, citing potential upside from the Foot Locker acquisition; low importance as analyst initiations typically have limited price impact, estimated.

The stock went ex-dividend for the quarterly cash dividend of $1.02 per share, which was announced on February 24, 2026.

The Board of Directors declared a quarterly cash dividend of $0.265 per common share on April 15, 2026, payable on July 1, 2026.

On April 14, 2026, the U.S. FDA refused to file partner Replimune's application for RP1 in combination with Opdivo for advanced melanoma due to study design concerns.

On April 14, 2026, MetLife recommended shareholders reject an unsolicited 'mini-tender' offer from Potemkin Limited to purchase shares at $44.20, which was approximately 41% below the market price of $75.36 on April 13, 2026.

The Board of Directors declared a 3% increase in the quarterly dividend to $1.0885 per share on April 14, 2026. The dividend is payable on May 15, 2026, to shareholders of record as of April 24, 2026.

CEO Elliott Hill purchased approximately $1 million of NKE stock on April 13, 2026, following a $1.06 million purchase by Director Timothy Cook on April 10, 2026. High importance is estimated as significant insider buying at multi-year lows typically signals a strong reversal with >10% price impact.

The U.S. FDA granted Priority Review for the Biologics License Application for ifinatamab deruxtecan for a type of small cell lung cancer on April 13, 2026. The PDUFA action date is set for October 10, 2026.

T. Rowe Price reported March 2026 month-end assets under management (AUM) of $1.71 trillion, a decrease from $1.80 trillion in the prior month, with net outflows of $3.2 billion.

On April 13, 2026, Chevron announced an asset swap agreement with Venezuela's PDVSA to consolidate its heavy oil position in the country.

Bank OZK's quarterly common dividend increased to $0.47 per share, with the ex-dividend date on 2026-04-13 and payment on 2026-04-20, signaling continued capital strength.